Publications
173
Citations
1,694
Est. group size
~1
Recurring co-author estimate
Active years
38
Publishing since 1989
Patrick W. Underwood's work centers on the surgical treatment of pancreatic and colorectal cancers, including robotic pancreatic surgery, patient outcomes, and the tumor microenvironment (such as immune cell infiltration in pancreatic tumors). Additional work covers surgical training and assessment, novel targeted drug approaches for pancreatic cancer, and cancer research infrastructure and equity initiatives.
Publication output was modest and variable from 2017-2022, spiked sharply in 2023, and has since settled into a steady pace of roughly 5-9 papers per year through 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Setting the Standard in Robotic Whipple Surgery
Annals of Surgery · 2026
- Building Equitable Cancer Research Infrastructure: Successful Transfer of Patient-Derived Xenograft Technology to a Historically Black University
UNC Libraries · 2026
- National utilization and outcomes of robotic pancreatoduodenectomy
HPB · 2026
- Neoadjuvant Therapy for Localized Pancreatic Cancer
Cancers · 2026
- Robotic Surgery for Pancreas Cancer
Surgical Oncology Clinics of North America · 2026
- Guiding Surgical Trainee Supervision Through Competency-Based Assessment: In Reply to Kapoor and Ray
Journal of the American College of Surgeons · 2025
- Abstract 4326: KRB-456: A novel KRAS G12D switch-I/II allosteric pocket binder that thwarts pancreatic cancer patient-derived tumors
Cancer Research · 2025
- 967: INFILTRATION OF MACROPHAGES AND MICROENVIRONMENT INFLAMMATORY PROTEINS IN PANCREATIC DUCTAL ADENOCARCINOMA
Gastroenterology · 2025
- Localized Pancreatic Cancer among Military Beneficiaries: A National Cancer Database Analysis
Military Medicine · 2025
- Author response for "Building Equitable Cancer Research Infrastructure: Successful Transfer of Patient-Derived Xenograft Technology to a Historically Black University"
2025
- Building Equitable Cancer Research Infrastructure: Successful Transfer of Patient-Derived Xenograft Technology to a Historically Black University
Cancer Control · 2025
- Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer
Cells · 2024
- Hepatic adenoma: evolution of a more individualized treatment approach
Journal of Gastrointestinal Surgery · 2024
- Simultaneous resection for colorectal cancer with synchronous liver metastases: current state-of-the-art
Journal of Gastrointestinal Surgery · 2024
- Precision Medicine for Metastatic Colorectal Cancer: Where Do We Stand?
Cancers · 2024
- Cancer Research×7
- Journal of the American College of Surgeons×6
- Cancer Epidemiology Biomarkers & Prevention×6
- Cancers×5
- HPB×5
- Arjun Mittra
Medicine · The Ohio State University
- Susan Tsai
Medicine · The Ohio State University
- Anne M. Noonan
Medicine · The Ohio State University
- Subhankar Chakraborty
Medicine · The Ohio State University
- Susan Tsai
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile